Patent Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur…

Basic data

Title:
Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten
Reference number (DPMA):
10 2006 058 183
Primary registration:
29/11/2006

Inventors

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

National patents

PCT Registration

Registration date:
31/10/2007
Registration number:
PCT/EP2007/009433

Nationalizations

Patent familiy:
10 2006 058 183, US12/474,184, EP20070819467, EP20110008821

US12/474,184
USA: United States Patent and Trademark Office
28/05/2009
31/12/2013
EP20070819467
European Patent Office
31/10/2007
25/05/2016
EP20110008821
European Patent Office
31/10/2007
30/11/2016
Help

will be deleted permanently. This cannot be undone.